chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Elevated sugar level since getting the second dose; Sore arm; Body aches; headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Elevated sugar level since getting the second dose), VACCINATION SITE PAIN (Sore arm), MYALGIA (Body aches), HEADACHE (headache) and FATIGUE (Fatigue) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Elevated sugar level since getting the second dose), VACCINATION SITE PAIN (Sore arm), MYALGIA (Body aches), HEADACHE (headache) and FATIGUE (Fatigue). At the time of the report, BLOOD GLUCOSE INCREASED (Elevated sugar level since getting the second dose), VACCINATION SITE PAIN (Sore arm), MYALGIA (Body aches), HEADACHE (headache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: elevated (High) Elevated blood glucose level.         No concomitant medications were provided No treatment medications were provided. Action taken with mRNA-1273 in response to the event was not applicable.
sugar level increased consistently since injection, some nausea, pain in pancreas and colon-mild to moderate. Same thing happened with vaccine dose #2 but much more severe than this booster dose.
Tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received BNT162b2 (BNT162B2), on 23Oct2021 as dose 3 (booster), single (Lot number: FE3592) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: Other Conditions: No. There were no concomitant medications. Vaccination history included: BNT162b2 (dose 1, single, Lot: EL3249), administration date: 23Jan2021, when the patient was 75-year-old, for COVID-19 IMMUNIZATION; BNT162b2 (dose 2, single, Lot: EN6201), administration date: 13Feb2021, when the patient was 75-year-old, for COVID-19 IMMUNIZATION. The following information was reported: TINNITUS (non-serious) with onset Oct2021, outcome "not recovered". Additional information: The patient received his 3rd dose of the Pfizer Covid vaccine, which was his first booster dose on 23Oct2021, and 3-5 days later he got tinnitus in both ears. He has spoken to his primary care doctor, and even had another booster dose on 10Jan2023 (Lot: GJ6742). He spoke to a hearing doctor but nobody seemed to care or saying anything about it. He stated the side effects were on the news all the time and a doctor mentioned that tinnitus could be a side effect of the vaccine. He saw the hearing doctor shortly after the tinnitus began and was told that other veterans have complained about it as well. The hearing doctor sent him home with a music machine to use for the tinnitus. The patient clarified that the doctor told him that other people said that they got tinnitus after getting the vaccine, but did not know what manufacturer's product those other patients received. The patient did not have other vaccinations within four weeks prior to the first administration date of the suspect vaccine and did not have family medical history relevant to the adverse event.; Sender's Comments: Linked Report(s) : PFIZER INC-202300056353 Same patient/drug/event, different doses;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On 09-SEP-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # H021941, expiration date 11-JUL-2014, dose and route were not provided). No adverse effects reported. Additional information has been requested.
Following vax pt exp fever of 103.5, lump, pain & swelling; high pitched scream that lasted more than 3 hrs;
Within minutes of receiving vax, the DTaP injection site became red and swollen. Pt became splotchy on face, neck, behind ears and down to chest area. Pt was treated with Benadryl and ice packs at site of DTaP and Hib. Pt would continuously cry.
Patients received the Moderna Covid 19 vaccine after temperature excursion; Patients received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In April 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion). On 27-Apr-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  The storage condition at the time of the excursion was reported as frozen storage. The affected batch lot numbers were reported as 065K21A and 045L21A. The temperatures excursion range was reported as maximum 30 Fahrenheit degrees and minimum minus18.9 Fahrenheit degrees. The vaccines suffered 2 temperature excursions since April, both of which lasted less than 1 minute. The vials were stored frozen. Visual inspection did not noted any vaccine state change. No treatment medication were provided.
Patient states onset of fever 1/12/11 which lasted 3 days with max 104.5 Severe muscle aches & back pain radiating down both legs, bil. upper extremity pain, bil hand swelling, numbness in left fingertips intermittently. Macular mottled looking rash entire body.
During a review of the regulatory authority internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
she could feel a "small sensation" going across her chest from her right to her left; tiredness; headache; chills; fever of 100.5; lymph glands were swollen; lethargic; stiffness; joint pain; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: unknown) via an unspecified route of administration in right arm on an unspecified date Tuesday afternoon (at the age of 73-yar-old) as single dose for COVID-19 immunization. Medical history and concomitant medications of the patient were not reported. Patient previously received Iodine during a gastrointestinal test "where they put the fluid through you" many decades ago and she experienced "gagging, coughing, throwing up, and eye swelled up." She was monitored for a couple of hours and then the symptoms went away. Patient reported that she gets "kind of lethargic" when she takes medications with iodine in them, like vitamins. Reportedly, after receiving vaccination on Tuesday afternoon [unspecified date] patient was okay the rest of the day. She reported that when she was sitting for 15 minutes after receiving the vaccine, she could feel a "small sensation" going across her chest from her right to her left. The next morning on Wednesday, she experienced tiredness, headache, chills, a fever of 100.5, and then later that night noticed her lymph glands were swollen. She reports that with the fever, she took Tylenol every 8 hours, and it went down to 100.1 and she felt better, and then states that when she went to her doctor later that day, they read her temperature as normal. This morning her temperature was 99.5. She stated that the lymph nodes were swollen on the same arm as where she received her injection, which was the right arm. She also reported feeling lethargic, stiffness, and joint pain on an unspecified date. Patient stated that her injection site was "okay", and her arm really was not sore. Patient asked how long she should expect her side effects to last. Patient would like to know if there was any iodine in the Pfizer BioNTech COVID-19 vaccine. Patient asked if she should get her second dose of the Pfizer BioNTech COVID-19 vaccine in the opposite arm that she received her first dose (state she got her injection in the right arm). Outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: EP7534), in left arm, on 08Apr2021 as dose 2, single (Lot number: ER8734), in left arm, on 08Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 31Mar2022 at 10:30 as dose 4 (booster), single (Lot number: FK9894) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "BMI of 26" (unspecified if ongoing), notes: Other medical history: BMI of 26. Concomitant medication(s) included: SIMVASTATIN, start date: 01Jan2015, stop date: 21Aug2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: Body mass index: (unspecified date) 26, notes: BMI of 26; SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (01Sep2022) Negative, notes: after negative rapid tests on days 8 and 10; (03Sep2022) Negative, notes: after negative, rapid tests on days 8 and 10; (04Sep2022) Positive, notes: Rebound COVID indicated by a Positive rapid test. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: Rebound COVID indicated by a Positive rapid test and bad head cold symptoms on day 12 after negative rapid tests on days 8 and 10.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
R hand swelling post H1N1 vaccine. BENADRYL 25mg po given at 9:20am. I spoke with pt on 11-19-09 and pt took one dose of BENADRYL last pm. He stated hand swelling subsided to a dime size area between thumb and index finger.
On the day of vaccination: Later that evening she was having HA and palpitations and just felt "off".  The weekend after vaccination: She started having bilateral hand, shoulder, and wrist joint pain and it has persisted until today. It has continued to worsen. She has taken Motrin, Tylenol, and Glucosamine. The Glucosamine worked the best in treating the joint pain for a week or so, but the pains have since come back and are worse. It is not only in her joints, but also muscular pain now. The Motrin and Tylenol help make it less painful, but do not relieve the pain.
Patient reports headache, diarrhea, slight increase in temp to Tmax of 100, onset of itching and swelling at injection site up to size of baseball. Rash and hives on chest.
The injection site started itching in the morning, 1 week from appointment.  Still itching by evening. Read online that it is a normal reaction, so I'm not worried, just wanted to report the issue.
Information has been received from a physician concerning a child (name, gender, and demographics were not provided) who received a dose of varicella virus vaccine live and developed a rash. It was unknown if medical attention was sought. No further information was given at the time of this report and the patient's status was unknown. There was no product quality complaint. The physician also reported at a 13 month old patient experienced vomiting, diarrhea, and a papular urticarial rash following exposure to the vaccinated patient (WAES0410USA03135). Follow up information was obtained from a registered nurse in the physician's office regarding this report. The nurse confirmed that this was a child from daycare but she indicated that she had no way to find out who the patient was. Additional information is not expected.
Warm, red, swollen area around injection site starting 3 days post injection - stable/slowly worsening over time - patient contacted pharmacy 6/1/20 and presented to urgent care 6/1/20 for a dx of celluitis. Treated with abx
A non-serious report of positive B strain test has been received from a nurse practitioner concerning a five-year-old male subsequent to FLUMIST. The patient's past medical history and concomitant medications are not provided. The patient received FLUMIST on 25-Aug-2009. On 31-Aug-2009, the patient tested positive for B strain of influenza. Outcome of the event was unknown. Reported causality assessment was not provided.
VARICELLA reaction; 3 small vesicles on left leg near injection site as well as a few other scattered vesicular lesions.
Immediate numbness if lips, tongue, and oral cavity with some swelling. Extremities also  tingly and felt numb with frequent heart palpitations,  and brain fog.  Mucus became thick and I needed to keep sipping water. I did not have any difficulty breathing or feel like my throat was swelling. I was sent home after observation period. At home, I saw that my laryngeal area and oral cavity were covered in hives. Within an hour, I developed a  bright facial rash. I tool Benadryl and facial rash and hives dissipated within 24 hours. The heart palpitations, brain fog,  fatigue, and intermittent nauseousness lasted  5 days.
redness and swelling reported on 11/12/19.  Employee evaluated on 11/14/19.
sudden onset shaking-pt placed supine w/leg elevated-lung sounds CTA;responsive but dazed;pulse ox 99% during entire time;began to hear faint wheezing;given epi;
Pfizer COVID-19 vaccine 1 (12/16/20) and 2 (1/5/21): Body aches, chills, fatigue, cold sweats, localized discomfort
Chief Complaint   short of breath, fever  History of Present Illness     65yo male with obesity, CAD s/p 5 stents (last stented in 2016), HTN, HLD, depression, neuropathy 2/2 cervical injury in 1990's, b/l glaucoma, h/o cornea transplant, BPH, presenting to the ER with 3-days history of headache, persistent cough, and malaise. Patient oxygenation worsened on 8/27 and was thus transferred to MICU on 60% FiO2 at 50 L/min. Patient reported that his grandson was visiting for a week 3 weeks ago. His grandson was sick at that time and found out he had Covid later. Patient then began to have persistent cough 3 days ago and had trouble breathing. He had Covid vaccine back in April-May 2021. Initial labs were notable for leukocytosis 19k, Cr 1.43 (Cr 1.3 baseline), elevated D-dimer 0.79, CRP 19.53. CXR showed bilateral airspace opacities. CTPE was negative for PE but showed multifocal opacities. Patient was started on remdesivir, dexamethasone, and barictinib.
Starting January 6th started having itching on my upper L eyelid. The itching/pain progressed despite warm compresses multiple times a day. The morning of January 8th had swelling and redness in upper eyelid which then lead to some extremely mild ptosis and inability to fully open eyelid.   I got concerned at work on the 8th because of the pain due to the swelling of the eyelid. I was able to be seen by my eye doctor the afternoon the 8th . He prescribed me topical steroid (Desonide).   Personally I felt like it felt different than a stye. He reported he didn't feel any bleb or any raised lesion that he felt was suspicious for a stye.   I hadn't used any new products/soaps or makeup on that one eyelid.  Of note, I did fine for the second vaccine.
CHILD RECEIVED 3 ROTAVIRUS VACCINES ON SCHEDULE AND POSITIVE FOR ROTAVIRUS 5/15/19. JUST WANTED TO BE MADE AWARE OF POSITIVE ROTAVIRUS AFTER  COMPLETE VACCINATION
Patient received vaccine after its expiration date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after its expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 014H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after its expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after its expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after its expiration date).    No concomitant medications were provided. Dosage text for suspect product was reported as unknown. No treatment medication was provided.    This case was linked to US-MODERNATX, INC.-MOD-2023-727965 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-727965:
9/26: 28yr old male who presents to ED via private car with complaints of diarrhea and nausea since Tuesday, 9/21/2021.  Patient states he was seen at ER on Wednesday and was diagnosed with food poisoning/gastroenteritis.  Patient states he was given bentyl, zofran odt, and imodium.  Patient states he has not taken the bentyl or zofran since yesterday morning and the imodium since Friday.  Patient states he is having 6+ episodes of diarrhea per day.  Denies pain. Denies any other issues at this time.   9/27 back to ED 28yr old male arrived to ED with complaints of diarrhea lasting over a week. He was seen in the clinic earlier today and then sent to ED for further eval. Stool sample obtained in clinic. He is pale. Feels weak. . Diarrhea has occurred about 5 times today. No vomiting today. He has been taking prescribed medications as ordered.       9/28 clinic visit: Plan: Gastrointeritis/diarrhea  Stool testing today. OP - LR bolus 1,000ml - Potassium 20 mEq - Zofran Continue Zofran prn at home Continue bland diet, avoid dairy products and monitor symptoms Avoid anti-diarrheals at this time. - Initiate flagyl twice a day for 7 days. Avoid all Alcohol.   Return in about 2 days (around 10/1/2021) for Recheck.
Constant pain and numbness in back, legs and arms. I saw my PCP two weeks after the shot. First he prescribed steroid which I took for 10 days, It didn't work. I went to see him again - he told me to take magnesium malate and referred to a rheumatologist. The rheumatologist did blood tests and he said that I don't have any inflammatory disease. He didn't find anything wrong but he said that my symptoms are similar to those of fibromyalgia. he referred me to a physical therapy. I have been going to a physical therapy 3 times a week for the last two months. Nothing works so far. The pain and numbness in my back, legs and arms are as strong as before.
Information has been received from a grandmother concerning her 2 year old granddaughter who "about 2 months ago" (in approximately June 2009), was vaccinated with a 0.5mL dose of VARIVAX (Merck) (LOT# not reported). In approximately June 2009, after receiving the vaccine the patient experienced "an allergic reaction and 5 days later broke out in a rash". The grandmother also stated that the patient's physician told them that the rash was from the vaccine virus "because the outbreak wasn't that bad and a virus outbreak from the vaccine looks different that when you've been exposed to the wild virus." The patient sought unspecified medical attention and had recovered on an unspecified date. No further information is available.
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 23-MAY-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally (LOT# R034700, expiry date 16-JUN-2020) for prophylaxis. The vaccine was exposed to a temperature of 34.2 Fahrenheit degrees (F) for 4 hours and 54 minutes. Digital data logger was involved. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA000862: US-009507513-1907USA000882: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000898: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000903: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1906USA011674: